Role of Cystatin C and Cysteine Proteinases in the Development of Mouse LS-Lymphosarcoma
- 27 Downloads
The growth of LS-lymphosarcoma in CBA mice was accompanied by a decrease in the content of the major extracellular inhibitor cystatin C in the tumor, plasma and, to a lesser extent, in tissued not involved in tumor process (liver and spleen). Cyclophosphamide in a dose of 50 mg/kg prolonged the life-span of animals and decreased tumor size by 80%. Cathepsin B and L activities in the tumor tissue increased by 3 and 7 times, respectively. Cystatin C content in the tumor tissue, spleen, and plasma also increased. Cystatin C assay in tumor tissue and plasma helps to predict the rate of tumor growth and to evaluate the efficiency of antitumor therapy.
Unable to display preview. Download preview PDF.
- 2.M. Abrahamson, Mol. Biol., 19, 127-136 (1990).Google Scholar
- 5.C. C. Calkins and B. F. Sloane, Biol. Chem. Hoppe Seyler, 356, No. 2, 71-80 (1995).Google Scholar
- 13.T. T. Lah, M. Cercek, A. Blejec, et al., Clin. Can. Res., 6, No. 1, 578-584 (2000).Google Scholar
- 14.O. N. Poteryaeva, O. V. Falameyeva, T. A. Korolenko, et al., Drugs Exp. Clin. Res., 26, Nos. 5-6, 137-142 (2000).Google Scholar